Recombinant ABL1 Monoclonal Antibody

This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t (9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410) . Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons.

JTK; Tyrosine-protein kinase ABL; Abelson tyrosine-protein kinase; Abelson murine leukemia viral oncogene homolog; ABL; JTK7; p150; c-ABL; v-abl; CHDSKM; c-ABL1; ABL1; bcr/abl; JTK7) ; Tyrosine-protein kinase ABL1; ABL1 (ABL) ; Abelson murine leukemia viral oncogene homolog 1; Abelson tyrosine-protein kinase 1; Abelson tyrosine protein kinase 1; Abl 1; ABL proto oncogene 1 non receptor tyrosine kinase; bcr/c abl oncogene protein; c ABL; c abl oncogene 1 non receptor tyrosine kinase; c abl oncogene 1 receptor tyrosine kinase; c ABL1; Proto oncogene tyrosine protein kinase ABL1; Proto-oncogene c-Abl; v abl; v abl Abelson murine leukemia viral oncogene homolog 1